𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical practice patterns and cost-effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

✍ Scribed by Patrick Fitzgibbons; Mary Kay Washington; Douglas Murphy

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
65 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of human epidermal growth facto
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004
✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been

Therapeutic effect of recombinant human
Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial
✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views